Structural magnetic resonance imaging in the practical assessment of dementia: Beyond exclusion

Lancet Neurology

Volumn 1, Issue 1, 2002, Pages 13-21

  Scheltens, Philip ^a   Fox, Nick ^c   Barkhof, Frederik ^b   De Carli, Charles ^d  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; APHASIA; BRAIN ATROPHY; BRAIN DYSFUNCTION; BRAIN MAPPING; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; ENTORHINAL CORTEX; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; MULTIINFARCT DEMENTIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROGNOSIS; REVIEW; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME; BRAIN; DEMENTIA; METHODOLOGY; PATHOLOGY;

BRAIN; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING;

EID: 0001792170     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(02)00002-9     Document Type: Review

References (80)

1. Ott A., Breteler M.M.B., van Harskamp F., et al. Prevalence of Alzheimer's disease and vascular dementia: association with education. BMJ. 310:1995;970-973.
2. Schenk D., Barbour R., Dunn W., et al. Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature. 400:1999;173-177.
3. Farina E., Pomati S., Mariani C. Observations on dementias with possible reversible symptoms. Aging. 11:1999;323-328.
4. Foster G.R., Scott D.A., Payne S. The use of CT scanning in dementia: a systematic review. Int J Techn Assess Health Care. 15:1999;406-423.
5. Chui H., Zhang Q. Evaluation of dementia: a systematic study of the usefulness of the American Academy of Neurology pratice parameters. Neurology. 49:1997;925-935.
6. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
7. Diagnostic and statistical manual of mental disorders. 4th edn: 1994;American Psychiatric Association, Washington, DC.
8. Chui H, Young Lee A. Clinical criteria for various dementia subtypes: Alzheimer disease (AD), vascular dementia (VaD), dementia with Lewy bodies (DLB), and frontotemporal dementia (FTD). In: Qizilbash N, Schneider L, Chui H, Brodaty H, Kaye J, Erkinjuntti T, eds. Evidence based dementia. Oxford: Blackwell Science (in press).
9. Petrovitch H., White L.R., Ross G.W., et al. Accuracy of clinical criteria for AD in the Honolulu-Asia aging study, a population based study. Neurology. 57:2001;226-234.
10. Varma A.R., Snowden J.S., Lloyd J.J., Talbot P.R., Mann D.M.A., Neary D. Evaluation of the NINCDS-ADRDA criteria in the differentiation of Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 66:1999;184-188.
11. Neary D., Snowden J.S., Gustafson L., et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 51:1998;1546-1554.
12. Román G.C., Tatemichi T.K., Erkinjuntti T., et al. Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Work Group. Neurology. 43:1993;250-260.
13. McKeith I.G., Galasko D., Kosaka K., et al. Consensus guidelines for the clinical and pathologic diagnoses of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 47:1996;1113-1124.
14. Knopman D.S., De Kosky S.T., Cummings J.L., et al. Diagnosis of dementia (an evidence based review): report of the quality standards subcommittee of the American Academy of Neurology. Neurology. 56:2001;1143-1155.
15. Jobst K.A., Smith A.D., Barker C.S., et al. Association of atrophy of the medial temporal lobe with reduced blood flow in the posterior parietotemporal cortex in patients with a clinical and pathological diagnosis of Alzheimer's disease. J Neurol Neurosurg Psychiatry. 55:1992;190-194.
16. De Leon M.J., George A.E., Stylopoulos L.A., Smith G., Miller D.C. Early marker for Alzheimer's disease: the atrophic hippocampus. Lancet. 2:1989;672-673.
17. De Leon M.J., George A.E., Golomb J., et al. Frequency of hippocampal formation atrophy in normal aging and Alzheimer's disease. Neurobiol Aging. 18:1997;1-11.
18. Frisoni G. Structural imaging in the clinical diagnosis of Alzheimer's disease: problems and tools. J Neurol Neurosurg Psychiatry. 70:2001;711-718.
19. Frisoni G., Geroldi C., Beltramello A., et al. Radial width of the temporal horn: a sensitive measure in Alzheimer's disease. AJNR Am J Neuroradiol. 23:2002;35-47.
20. De Carli C., Kay J.A., Horwitz B., et al. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer's type. Neurology. 40:1990;872-883.
21. Davis P.C., Gearing M., Gray L., et al. The CERAD experience, part VIII: neuroimaging-neuropathology correlates of temporal changes in Alzheimer's disease. Neurology. 45:1995;178-179.
22. Bobinski M., De Leon M.J., Wegiel J., et al. The histological validation of post mortem magnetic resonance imaging-determined hippocampal volume in Alzheimer's disease. Neuroscience. 95:2000;721-725.
23. Scheltens P., Leys D., Barkhof F., et al. Atrophy of medial temporal lobes on MRI in probable Alzheimer's disease and normal aging: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 55:1992;967-972.
24. Erkinjuntti T., Lee D.H., Gao F., et al. Temporal lobe atrophy on magnetic resonance imaging in the diagnosis of early Alzheimer's disease. Arch Neurol. 50:1993;305-310.
25. Frisoni G.B., Beltramello A., Weiss C., Geroldi C., Bianchetti A., Trabucchi M. Linear measures of atrophy in mild Alzheimer's disease. AJNR Am J Neuroradiol. 17:1996;913-923.
26. De Leon M.J., Convit A., George A.E., et al. In vivo structural studies of the hippocampus in normal aging and in incipient Alzheimer's disease. Ann NY Acad Sci. 17:1996;1-13.
27. O'Brien J.T., Desmond P., Ames D., Schweitzer I., Chiu E., Tress B. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol Med. 27:1997;1267-1275.
28. Scheltens P., Launer L.J., Barkhof F., Weinstein H.C., Jonker C. The diagnostic value of magnetic resonance imaging and technetium 99m-HMPAO single-photon-emission-computed-tomography for the diagnosis of Alzheimer disease in a community-dwelling elderly population. Alzheimer Dis Assoc Disord. 11:1997;63-70.
29. Pucci E., Belardinelli N., Regnicolo L., et al. Hippocampus and parahippocampal gyrus linear measurements based on magnetic resonance in Alzheimer's disease. Eur Neurol. 39:1998;16-25.
30. Barber R., Gholkar A., Scheltens P., Ballard C., McKeith I.G., O'Brien J.T. Medial temporal lobe atrophy on MRI in dementia with Lewy bodies. Neurology. 52:1999;1153-1158.
31. Desmond P.M., O'Brien J.T., Tress B.M., et al. Volumetric and visual assessment of the mesial temporal structures in Alzheimer's disease. Aust NZ J Med. 24:1994;547-553.
32. Wahlund L.O., Julin P., Lindqvist J., Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry. 69:2000;630-635.
33. Hanyu H., Tetsuichi A., Sakurai H., Takasaki M., Shindo H., Abe K. Magnetization transfer measurements of the hippocampus in the early diagnosis of Alzheimer's disease. J Neurol Sci. 188:2001;79-84.
34. Wahlund L.-O., Julin P., Lindqvist J., Scheltens P. Visual assessment of medial temporal lobe atrophy in demented and healthy controls: correlation with volumetry. Psychiatry Res. 90:1999;193-199.
35. Scheltens P., Launer L.J., Barkhof F., Weinstein H.C., van Gool W.A. Visual assessment of medical temporal lobe atrophy on magnetic resonance imaging; interobserver reliability. J Neurol. 242:1995;557-560.
36. Golomb J., De Leon M.J., Kluger A., George A.E., Tarshish C., Ferris S.H. Hippocampal atrophy in normal aging. Arch Neurol. 50:1993;967-973.
37. Galton C.J., Gomez-Anson B., Antoun N., et al. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J Neurol Neurosurg Psychiatry. 70:2001;165-173.
38. Chan D., Fox N.C., Scahill R.I., et al. Patterns of temporal lobe atrophy in semantic dementia and Alzheimer's disease. Ann Neurol. 49:2001;433-442.
39. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's disease diagnostic and treatment centers. Neurology. 42:1992;473-480.
40. Boone K.B., Miller B.L., Lesser J.M., et al. Neuropsychological correlates of white-matter lesions in healthy elderly subjects: a threshold effect. Arch Neurol. 49:1992;549-554.
41. Scheltens P., Kittner B. Preliminary results from an MRI/CT-based database for vascular dementia and Alzheimer's disease. Ann NY Acad Sci. 903:2000;542-547.
42. Erkinjuntti T., Inzitari D., Pantoni L., et al. Research criteria for subcortical vascular dementia in clinical trials. J Neural Transm. 59:(suppl):2000;23-30.
43. Scheltens P., Erkinjunti T., Leys D., et al. White matter changes on CT and MRI: an overview of visual rating scales. Eur Neurol. 39:1998;80-89.
44. Wahlund L.O., Barkhof F., Fazekas F., et al. A new rating scale for age related white matter changes (ARWMC) applicable to MRI and CT. Stroke. 32:2001;1318-1322.
45. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesberry W.R. Brain infarction and the clinical expression of Alzheimer disease: the Nun Study. JAMA. 277:1997;813-817.
46. Swan G.E., De Carli C., Miller B.L., et al. Association of midlife blood pressure to late-life cognitive decline and brain morphology. Neurology. 51:1998;986-993.
47. Breteler M.M., Van Amerongen N.M., Van Swieten J.C., et al. Cognitive correlates of ventricular enlargement and cerebral white matter lesions on MRI: the Rotterdam Study. Stroke. 25:1994;1109-1115.
48. Longstreth W.T. Jr, Manolio T.A., Arnold A., et al. Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people: the cardiovascular health study. Stroke. 27:1996;1274-1282.
49. DeCarli C., Miller B.L., Swan G.E., Reed T., Wolf P.A., Carmelli D. Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, And Blood Institute twin study. Arch Neurol. 58:2001;643-647.
50. Wolf H., Ecke G.M., Bettin S., Dietrich J., Gertz H.J. Do white matter changes contribute to the subsequent development of dementia in patients with mild cognitive impairment? A longitudinal study. Int J Geriatr Psychiatry. 15:2000;803-812.
51. Leys D., Scheltens P., Steinling M. White-matter lesions on CT in Alzheimer patients. Acta Neurol Scand. 84:1991;264-265.
52. Scheltens P., Barkhof F., Valk J., et al. White matter lesions on magnetic resonance imaging in clinically diagnosed Alzheimer's disease: evidence for heterogeneity. Brain. 115:1992;735-748.
53. De Carli C., Grady C.L., Clark C.M., et al. Comparison of positron emission tomography, cognition, and brain volume in Alzheimer's disease with and without severe abnormalities of white matter. J Neurol Neurosurg Psychiatry. 60:1996;158-167.
54. Reed B.R., Eberling J.L., Mungas D., Weiner M.W., Jagust W.J. Memory failure has different mechanisms in subcortical stroke and Alzheimer's disease. Ann Neurol. 48:2000;275-284.
55. Reed B.R., Eberling J.L., Mungas D., Weiner M., Jagust W.J. Frontal lobe hypometabolism predicts cognitive decline in patients with lacunar infarcts. Arch Neurol. 58:2001;493-497.
56. Massoud F., Devi G., Moroney J.T., et al. The role of routine laboratory studies and neuroimaging in the diagnosis of dementia: a clinicopathological study. J Am Geriatr Soc. 48:2000;1204-1210.
57. Forette F., Seux M.L., Staessen J.A., et al. Prevention of dementia in a randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet. 352:1998;1347-1351.
58. Schroter A., Zerr I., Henkel K., Tschampa H.J., Finkenstaedt M., Poser S. Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease. Arch Neurol. 57:2000;1751-1757.
59. Collie D.A., Sellar R.J., Zeidler M., Colchester A.C., Knight R., Will R.G. MRI of Creutzfeldt-Jakob disease: imaging features and recommended MRI protocol. Clin Radiol. 56:2001;726-739.
60. Vanneste J.A. Diagnosis and management of normal-pressure hydrocephalus. J Neurol. 247:2000;5-14.
61. Gado M., Hughes C.P., Danziger W., Chi D., Jost G., Berg L. Volumetric measurements of the cerebrospinal fluid spaces in demented subjects and controls. Radiology. 144:1982;535-538.
62. DeCarli C., Haxby J.V., Gillette J.A., Teichberg D., Rapoport S.I., Schapiro M.B. Longitudinal changes in lateral ventricular volume in patients with dementia of the Alzheimer type. Neurology. 42:1992;2029-2036.
63. Jobst K.A., Smith A.D., Szatmari M., et al. Rapidly progressing atrophy of medial temporal lobe in Alzheimer's disease. Lancet. 343:1994;829-830.
64. Jack C.R. Jr, Petersen R.C., Xu Y., et al. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 51:1998;993-999.
65. Fox N.C., Freeborough P.A. Brain atrophy progression measured from registered serial MRI: validation and application to Alzheimer's disease. J Magn Reson Imaging. 7:1997;1069-1075.
66. Fox N.C., Warrington E.K., Rossor M.N. Serial magnetic resonance imaging of cerebral atrophy in preclinical Alzheimer's disease. Lancet. 353:1999;2125.
67. Fox N.C., Crum W.R., Scahill R.I., Stevens J.M., Janssen J., Rossor M.N. The onset and progression of Alzheimer's disease imaged with voxel compression mapping of serial MRI. Lancet. 358:2001;201-205.
68. Juottonen K., Laakso M.P., Partanen K., Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol. 20:1999;139-144.
69. Du A.T., Schuff N., Amend D., et al. Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease. J Neurol Neurosurg Psychiatry. 71:2001;441-447.
70. Jack C.R., Petersen R.C., Xu Y.C., et al. Prediction of AD with MRI based hippocampal volume in mild cognitive impairment. Neurology. 52:1999;1397-1403.
71. De Leon M., George A., Convit A., et al. The radiologic prediction of Alzheimer's disease: the atrophic hippocampal formation. AJNR Am J Neuroradiol. 14:1993;897-906.
72. Convit A., De Asis J., De Leon M.J., Tarshish C.Y., DeSanti S., Rusinek H. Atrophy of the medial occipitotemporal, inferior, and middle temporal gyri in non demented elderly predict decline to Alzheimer's disease. Neurobiol Aging. 21:2000;19-26.
73. Visser P.J., Scheltens P., Verhey F.R.J., et al. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J Neurol. 246:1999;477-485.
74. Toga A.W., Mazziotta J.C. Brain mapping. 1996;Academic Press, San Diego.
75. Thompson P.M., Mega M.S., Wood R.P., et al. Cortical change in Alzheimer's disease detected with a disease-specific population-based brain atlas. Cerebral Cortex. 11:2001;1-16.
76. Ashburner J., Friston K.J. Voxel-based morphometry: the methods. NeuroImage. 11:2000;805-821.
77. Rombouts S.A.R.B., Barkhof F., Witter M.P., Scheltens P. Unbiased whole-brain analysis of gray matter loss in Alzheimer's disease. Neurosci Lett. 285:2000;231-233.
78. Baron J.C., Chetelat G., Desgranges B., et al. In vivo mapping of gray matter loss with voxel-based morphometry in mild Alzheimer's disease. NeuroImage. 14:2001;298-309.
79. Burton EJ, Karas GB, Paling S, et al. Patterns of cerebral atrophy in dementia with Lewy bodies using voxel-based morphometry. NeuroImage (in press).
80. Csernansky J.G., Wang L., Joshi S., et al. Early DAT is distinguished from aging by high-dimensional mapping of the hippocampus. Neurology. 55:2000;1636-1643.